Jason Haas, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 7,138 shares at $292.81 ($2.1M) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $2.1M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SYRS | SELL | 2024-11-20 | $29K | — | Filing → |
| SYRS | BUY | 2024-09-12 | $292K | — | Filing → |